Drug therapies activating the power of your body

Palatin Technologies develops peptide therapeutics for diseases with significant unmet medical need and commercial potential.

Female Sexual Dysfunction

Bremelanotide is an on-demand treatment for the most common type of female sexual dysfunction.

Natriuretic peptide mimetics for heart failure, providing increased therapeutic options.

Peptide therapeutics to help regulate eating behavior and energy balance, leading to decreased food intake and weight loss.

Using the melanocortin receptor-1 system to help control inflammatory and autoimmune diseases like inflammatory bowel disease, nephritis and uveitis.





Status of our clinical and preclinical programs, including our inflammatory and heart disease programs.

Learn about Palatin, including press releases, presentations, filings with the Securities and Exchange Commission and more.

The latest news about Palatin, with the full text of press releases issued by Palatin.

Scheduled presentations by Palatin senior management, quarterly calls, scientific presentations and other upcoming events.

Palatin’s corporate presentation, with an emphasis on bremelanotide for female sexual dysfunction and other pipeline development programs.